Aspiriant LLC’s Vanguard Materials ETF VAW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $524K | Sell |
2,324
-196
| -8% | -$44.8K | 0.01% | 214 |
|
|
2025
Q4 | $523K | Buy |
2,520
+196
| +8% | +$39.5K | 0.02% | 208 |
|
|
2025
Q3 | $476K | Hold |
2,324
| – | – | 0.01% | 204 |
|
|
2025
Q2 | $453K | Sell |
2,324
-566
| -20% | -$106K | 0.01% | 208 |
|
|
2025
Q1 | $546K | Hold |
2,890
| – | – | 0.02% | 181 |
|
|
2024
Q4 | $543K | Sell |
2,890
-105
| -4% | -$21.6K | 0.02% | 185 |
|
|
2024
Q3 | $633K | Sell |
2,995
-9
| -0.3% | -$1.8K | 0.02% | 175 |
|
|
2024
Q2 | $579K | Buy |
3,004
+9
| +0.3% | +$1.79K | 0.02% | 179 |
|
|
2024
Q1 | $612K | Hold |
2,995
| – | – | 0.03% | 176 |
|
|
2023
Q4 | $569K | Sell |
2,995
-52
| -2% | -$9.13K | 0.03% | 181 |
|
|
2023
Q3 | $526K | Buy |
3,047
+100
| +3% | +$18.1K | 0.03% | 173 |
|
|
2023
Q2 | $536K | Sell |
2,947
-746
| -20% | -$130K | 0.03% | 177 |
|
|
2023
Q1 | $657K | Hold |
3,693
| – | – | 0.03% | 159 |
|
|
2022
Q4 | $629K | Buy |
3,693
+54
| +1% | +$9.07K | 0.03% | 161 |
|
|
2022
Q3 | $540K | Hold |
3,639
| – | – | 0.03% | 164 |
|
|
2022
Q2 | $582K | Hold |
3,639
| – | – | 0.03% | 156 |
|
|
2022
Q1 | $705K | Sell |
3,639
-276
| -7% | -$51.6K | 0.04% | 150 |
|
|
2021
Q4 | $772K | Sell |
3,915
-45
| -1% | -$8.47K | 0.04% | 150 |
|
|
2021
Q3 | $686K | Hold |
3,960
| – | – | 0.04% | 143 |
|
|
2021
Q2 | $713K | Buy |
3,960
+1,850
| +88% | +$342K | 0.04% | 138 |
|
|
2021
Q1 | $366K | Hold |
2,110
| – | – | 0.02% | 163 |
|
|
2020
Q4 | $331K | Sell |
2,110
-50
| -2% | -$7.36K | 0.02% | 164 |
|
|
2020
Q3 | $291K | Sell |
2,160
-75
| -3% | -$9.94K | 0.02% | 184 |
|
|
2020
Q2 | $268K | Sell |
2,235
-643
| -22% | -$72.3K | 0.02% | 163 |
|
|
2020
Q1 | $276K | Sell |
2,878
-1,047
| -27% | -$124K | 0.03% | 163 |
|
|
2019
Q4 | $528K | Sell |
3,925
-526
| -12% | -$67.8K | 0.05% | 133 |
|
|
2019
Q3 | $565K | Sell |
4,451
-571
| -11% | -$71.7K | 0.05% | 135 |
|
|
2019
Q2 | $643K | Sell |
5,022
-1,738
| -26% | -$216K | 0.05% | 133 |
|
|
2019
Q1 | $833K | Sell |
6,760
-889
| -12% | -$107K | 0.07% | 124 |
|
|
2018
Q4 | $847K | Sell |
7,649
-1,345
| -15% | -$160K | 0.06% | 115 |
|
|
2018
Q3 | $1.19M | Sell |
8,994
-1,197
| -12% | -$160K | 0.1% | 101 |
|
|
2018
Q2 | $1.34M | Sell |
10,191
-909
| -8% | -$121K | 0.11% | 94 |
|
|
2018
Q1 | $1.43M | Buy |
+11,100
| New | +$1.52M | 0.12% | 85 |
|
|
2017
Q4 | – | Sell |
-15,840
| Closed | -$2.04M | – | 174 |
|
|
2017
Q3 | $2.04M | Sell |
15,840
-3,502
| -18% | -$435K | 0.17% | 75 |
|
|
2017
Q2 | $2.35M | Sell |
19,342
-2,143
| -10% | -$257K | 0.2% | 71 |
|
|
2017
Q1 | $2.56M | Sell |
21,485
-760
| -3% | -$89.7K | 0.22% | 72 |
|
|
2016
Q4 | $2.5M | Sell |
22,245
-350
| -2% | -$38.3K | 0.23% | 67 |
|
|
2016
Q3 | $2.42M | Sell |
22,595
-11,812
| -34% | -$1.27M | 0.24% | 60 |
|
|
2016
Q2 | $3.7M | Buy |
34,407
+2,553
| +8% | +$261K | 0.35% | 49 |
|
|
2016
Q1 | $3.13M | Buy |
+31,854
| New | +$2.86M | 0.3% | 52 |
|
Other funds holding VAW
BCMIO
PCH
Aspiriant LLC's VAW Position: Q1 2026 in Review
Aspiriant LLC reduced its Vanguard Materials ETF (VAW) stake by 7.8% in Q1 2026, selling an estimated $44.8K and leaving 2,324 shares worth $524K. The position accounts for 0.01% of the portfolio, ranked #214.
Aspiriant LLC first reported a position in VAW in Q1 2016 and has held it in 40 quarters since. The position peaked at $3.7M in Q2 2016. 406 funds tracked by Wall St. Rank hold VAW as of Q1 2026.
- Aspiriant LLC held 2,324 shares of Vanguard Materials ETF worth $524K as of Q1 2026.
- Aspiriant LLC sold 196 Vanguard Materials ETF shares in Q1 2026, an estimated $44.8K.
- Vanguard Materials ETF made up 0.01% of Aspiriant LLC's portfolio in Q1 2026, its #214 holding.
- Aspiriant LLC first reported a position in Vanguard Materials ETF in Q1 2016 and has held it in 40 quarters since.
- Aspiriant LLC's Vanguard Materials ETF position peaked at $3.7M in Q2 2016.
- 406 funds tracked by Wall St. Rank held Vanguard Materials ETF as of Q1 2026.
Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.